EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems

Ruslan Safarov, Olga Fedotova, Anastasia Uvarova, Mariia Gordienko, Natalia Menshutina iD

Pharmaceuticals · 07.09.2024 · 17 (9) · 1180

DOI: 10.3390/ph17091180 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 07.09.2024. Verfasst von Ruslan Safarov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent decades, there has been an increased interest in the development of intranasal delivery systems for active pharmaceutical ingredients (APIs) not only for treating local nasal diseases but also for treating systemic diseases, central nervous system (CNS) disorders, and vaccine delivery. The nasal cavity possesses a unique set of anatomical characteristics for delivering active pharmaceutical ingredients, but there are several limitations that recent research in the field of the intranasal administration of APIs aims to overcome. For the effective delivery of nasal preparations, active pharmaceutical ingredients are incorporated into various micro- and nanosystems. Some of the most commonly encountered API delivery systems in the scientific literature include liposomal systems, polymer particles with mucoadhesive properties, in situ gels, nano- and microemulsions, and solid lipid particles. This article provides a review of research on the development of nasal preparations for treating local nasal cavity diseases (in particular, for antibiotic delivery), systemic diseases (analgesics, drugs for cardiovascular diseases, antiviral and antiemetic drugs), CNS disorders (Alzheimer’s disease, Parkinson’s disease, epilepsy, schizophrenia, depression), and vaccine delivery. The literature data show that active research is underway to reformulate drugs of various pharmacotherapeutic groups into a nasal form.

Schlagwörter

Stichwörter der Autor:innen

intranasal drug delivery systemsmethods to improve API deliverynasal medications

Autor:innen und Institutionen

  • Department of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia.

ORCID-Profile: Natalia Menshutina

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Safarov, R., Fedotova, O., Uvarova, A., Gordienko, M., & Menshutina, N. (2024). Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems. Pharmaceuticals, 17(9), 1180. https://doi.org/10.3390/ph17091180

Vancouver

Safarov R, Fedotova O, Uvarova A, Gordienko M, Menshutina N. Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems. Pharmaceuticals. 2024;17(9):1180. doi:10.3390/ph17091180

BibTeX
@article{Safarov2024,
  author = {Safarov, Ruslan and Fedotova, Olga and Uvarova, Anastasia and Gordienko, Mariia and Menshutina, Natalia},
  title = {Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {9},
  pages = {1180},
  doi = {10.3390/ph17091180}
}
Kostenlos starten →